Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Nevis Brands Inc C.NEVI

Alternate Symbol(s):  PSCBF

Nevis Brands Inc., formerly Pascal Biosciences Inc., provides cannabis brands throughout the United States. The Company provides products in Washington, Oregon, California, Ohio, Arizona and Colorado through partners and licensees. Its products include Major, which is a cannabis beverage. Major is a high-dose tetrahydrocannabinol (THC) beverage that delivers a consistent cannabis experience... see more

CSE:NEVI - Post Discussion

Nevis Brands Inc > If costs hold NEVI is $100,000+ Ebitda Qtrly at $500k revs
View:
Post by OwnerzzZ on Apr 17, 2024 1:31pm

If costs hold NEVI is $100,000+ Ebitda Qtrly at $500k revs

Basically would have been breakeven at $400,000 revenues (even w/ extra costs this quarter). Assuming costs stay same, or reduce as per guidance, would have $100,000 Ebitda per quarter at $500,000 revenues. That is very foreseeable and achievable and equates to approx. 10x cash flow valauation at $4M cap.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities